-
Je něco špatně v tomto záznamu ?
PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress ApcMin-Triggered Intestinal Tumor Formation
AL. Farrall, M. Lienhard, C. Grimm, H. Kuhl, SHM. Sluka, M. Caparros, J. Forejt, B. Timmermann, R. Herwig, BG. Herrmann, M. Morkel
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1941 do Před 1 rokem
Freely Accessible Science Journals
od 1941 do Před 1 rokem
Open Access Digital Library
od 1941-01-01
Open Access Digital Library
od 1941-01-01
- MeSH
- beta-katenin genetika metabolismus MeSH
- genetická predispozice k nemoci MeSH
- geny APC * MeSH
- kolorektální nádory genetika patologie prevence a kontrola MeSH
- mutace * MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- nádorová transformace buněk genetika metabolismus patologie MeSH
- proteiny Wnt genetika metabolismus MeSH
- střeva patologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Genetic predisposition affects the penetrance of tumor-initiating mutations, such as APC mutations that stabilize β-catenin and cause intestinal tumors in mice and humans. However, the mechanisms involved in genetically predisposed penetrance are not well understood. Here, we analyzed tumor multiplicity and gene expression in tumor-prone ApcMin/+ mice on highly variant C57BL/6J (B6) and PWD/Ph (PWD) genetic backgrounds. (B6 × PWD) F1 APCMin offspring mice were largely free of intestinal adenoma, and several chromosome substitution (consomic) strains carrying single PWD chromosomes on the B6 genetic background displayed reduced adenoma numbers. Multiple dosage-dependent modifier loci on PWD chromosome 5 each contributed to tumor suppression. Activation of β-catenin-driven and stem cell-specific gene expression in the presence of ApcMin or following APC loss remained moderate in intestines carrying PWD chromosome 5, suggesting that PWD variants restrict adenoma initiation by controlling stem cell homeostasis. Gene expression of modifier candidates and DNA methylation on chromosome 5 were predominantly cis controlled and largely reflected parental patterns, providing a genetic basis for inheritance of tumor susceptibility. Human SNP variants of several modifier candidates were depleted in colorectal cancer genomes, suggesting that similar mechanisms may also affect the penetrance of cancer driver mutations in humans. Overall, our analysis highlights the strong impact that multiple genetic variants acting in networks can exert on tumor development. SIGNIFICANCE: These findings in mice show that, in addition to accidental mutations, cancer risk is determined by networks of individual gene variants.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019504
- 003
- CZ-PrNML
- 005
- 20210830101103.0
- 007
- ta
- 008
- 210728s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1158/0008-5472.CAN-20-1480 $2 doi
- 035 __
- $a (PubMed)33154092
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Farrall, Alexandra L $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia
- 245 10
- $a PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress ApcMin-Triggered Intestinal Tumor Formation / $c AL. Farrall, M. Lienhard, C. Grimm, H. Kuhl, SHM. Sluka, M. Caparros, J. Forejt, B. Timmermann, R. Herwig, BG. Herrmann, M. Morkel
- 520 9_
- $a Genetic predisposition affects the penetrance of tumor-initiating mutations, such as APC mutations that stabilize β-catenin and cause intestinal tumors in mice and humans. However, the mechanisms involved in genetically predisposed penetrance are not well understood. Here, we analyzed tumor multiplicity and gene expression in tumor-prone ApcMin/+ mice on highly variant C57BL/6J (B6) and PWD/Ph (PWD) genetic backgrounds. (B6 × PWD) F1 APCMin offspring mice were largely free of intestinal adenoma, and several chromosome substitution (consomic) strains carrying single PWD chromosomes on the B6 genetic background displayed reduced adenoma numbers. Multiple dosage-dependent modifier loci on PWD chromosome 5 each contributed to tumor suppression. Activation of β-catenin-driven and stem cell-specific gene expression in the presence of ApcMin or following APC loss remained moderate in intestines carrying PWD chromosome 5, suggesting that PWD variants restrict adenoma initiation by controlling stem cell homeostasis. Gene expression of modifier candidates and DNA methylation on chromosome 5 were predominantly cis controlled and largely reflected parental patterns, providing a genetic basis for inheritance of tumor susceptibility. Human SNP variants of several modifier candidates were depleted in colorectal cancer genomes, suggesting that similar mechanisms may also affect the penetrance of cancer driver mutations in humans. Overall, our analysis highlights the strong impact that multiple genetic variants acting in networks can exert on tumor development. SIGNIFICANCE: These findings in mice show that, in addition to accidental mutations, cancer risk is determined by networks of individual gene variants.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorová transformace buněk $x genetika $x metabolismus $x patologie $7 D002471
- 650 _2
- $a kolorektální nádory $x genetika $x patologie $x prevence a kontrola $7 D015179
- 650 12
- $a geny APC $7 D017491
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a střeva $x patologie $7 D007422
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a proteiny Wnt $x genetika $x metabolismus $7 D051153
- 650 _2
- $a beta-katenin $x genetika $x metabolismus $7 D051176
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lienhard, Matthias $u Max Planck Institute for Molecular Genetics, Berlin, Germany
- 700 1_
- $a Grimm, Christina $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u Department of Translational Epigenetics and Tumor Genetics, University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Kuhl, Heiner $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u Leibniz-Institute of Freshwater Ecology and Inland Fisheries, Department of Ecophysiology and Aquaculture, Berlin, Germany
- 700 1_
- $a Sluka, Susanna H M $u Max Planck Institute for Molecular Genetics, Berlin, Germany
- 700 1_
- $a Caparros, Marta $u Max Planck Institute for Molecular Genetics, Berlin, Germany
- 700 1_
- $a Forejt, Jiri $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vestec, Prague, Czech Republic
- 700 1_
- $a Timmermann, Bernd $u Max Planck Institute for Molecular Genetics, Berlin, Germany
- 700 1_
- $a Herwig, Ralf $u Max Planck Institute for Molecular Genetics, Berlin, Germany
- 700 1_
- $a Herrmann, Bernhard G $u Max Planck Institute for Molecular Genetics, Berlin, Germany. Markus.Morkel@charite.de herrmann@molgen.mpg.de $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics, Berlin, Germany
- 700 1_
- $a Morkel, Markus $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany. Markus.Morkel@charite.de herrmann@molgen.mpg.de
- 773 0_
- $w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 81, č. 1 (2021), s. 38-49
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33154092 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101103 $b ABA008
- 999 __
- $a ok $b bmc $g 1690350 $s 1139950
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 81 $c 1 $d 38-49 $e 20201105 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
- LZP __
- $a Pubmed-20210728